Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terrence R Burke

Showing results (31-40 of 169) with videos related to

Pageof 17
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 18, 2007
Protected aminooxyprolines for expedited library synthesis: application to Tsg101-directed proline-oxime containing peptidesFa Liu, Andrew G Stephen, Robert J Fisher, et al.
Bioconjugate Chemistry|November 2, 2019
Site-Specific Lysine Arylation as an Alternative Bioconjugation Strategy for Chemically Programmed Antibodies and Antibody-Drug ConjugatesDobeen Hwang, Kohei Tsuji, HaJeung Park, et al.
Journal of Molecular Biology|September 17, 2005
Crystal structures of a high-affinity macrocyclic peptide mimetic in complex with the Grb2 SH2 domainJason Phan, Zhen-Dan Shi, Terrence R Burke, et al.
Tetrahedron|June 24, 2014
Preparation of orthogonally protected (<i>2S, 3R</i>)-2-amino-3-methyl-4-phosphonobutyric acid (Pmab) as a phosphatase-stable phosphothreonine mimetic and its use in the synthesis of Polo-box domain-binding peptidesFa Liu, Jung-Eun Park, Kyung S Lee, et al.
Journal of Medicinal Chemistry|June 13, 2003
Utilization of a beta-aminophosphotyrosyl mimetic in the design and synthesis of macrocyclic Grb2 SH2 domain-binding peptidesKyeong Lee, Manchao Zhang, Hongpeng Liu, et al.
F1000Research|July 20, 2017
Current progress and future perspectives in the development of anti-polo-like kinase 1 therapeutic agentsJung-Eun Park, David Hymel, Terrence R Burke, et al.
Journal of Computer-Aided Molecular Design|August 3, 2005
Model of full-length HIV-1 integrase complexed with viral DNA as template for anti-HIV drug designRajeshri G Karki, Yun Tang, Terrence R Burke, et al.
Future Medicinal Chemistry|March 24, 2011
Authentic HIV-1 integrase inhibitorsChenzhong Liao, Christophe Marchand, Terrence R Burke, et al.
Bioorganic & Medicinal Chemistry|June 17, 2009
Diketoacid-genre HIV-1 integrase inhibitors containing enantiomeric arylamide functionalityXue Zhi Zhao, Kasthuraiah Maddali, Christophe Marchand, et al.
Viruses|January 25, 2025
Comparative Analyses of Antiviral Potencies of Second-Generation Integrase Strand Transfer Inhibitors (INSTIs) and the Developmental Compound 4d Against a Panel of Integrase Quadruple MutantsSteven J Smith, Xue Zhi Zhao, Stephen H Hughes, et al.
Pageof 17

Showing results (31-40 of 169) with videos related to

Sort By:
Pageof 17
Bioorganic & Medicinal Chemistry Letters|December 18, 2007
Protected aminooxyprolines for expedited library synthesis: application to Tsg101-directed proline-oxime containing peptidesFa Liu, Andrew G Stephen, Robert J Fisher, et al.
Bioconjugate Chemistry|November 2, 2019
Site-Specific Lysine Arylation as an Alternative Bioconjugation Strategy for Chemically Programmed Antibodies and Antibody-Drug ConjugatesDobeen Hwang, Kohei Tsuji, HaJeung Park, et al.
Journal of Molecular Biology|September 17, 2005
Crystal structures of a high-affinity macrocyclic peptide mimetic in complex with the Grb2 SH2 domainJason Phan, Zhen-Dan Shi, Terrence R Burke, et al.
Tetrahedron|June 24, 2014
Preparation of orthogonally protected (<i>2S, 3R</i>)-2-amino-3-methyl-4-phosphonobutyric acid (Pmab) as a phosphatase-stable phosphothreonine mimetic and its use in the synthesis of Polo-box domain-binding peptidesFa Liu, Jung-Eun Park, Kyung S Lee, et al.
Journal of Medicinal Chemistry|June 13, 2003
Utilization of a beta-aminophosphotyrosyl mimetic in the design and synthesis of macrocyclic Grb2 SH2 domain-binding peptidesKyeong Lee, Manchao Zhang, Hongpeng Liu, et al.
F1000Research|July 20, 2017
Current progress and future perspectives in the development of anti-polo-like kinase 1 therapeutic agentsJung-Eun Park, David Hymel, Terrence R Burke, et al.
Journal of Computer-Aided Molecular Design|August 3, 2005
Model of full-length HIV-1 integrase complexed with viral DNA as template for anti-HIV drug designRajeshri G Karki, Yun Tang, Terrence R Burke, et al.
Future Medicinal Chemistry|March 24, 2011
Authentic HIV-1 integrase inhibitorsChenzhong Liao, Christophe Marchand, Terrence R Burke, et al.
Bioorganic & Medicinal Chemistry|June 17, 2009
Diketoacid-genre HIV-1 integrase inhibitors containing enantiomeric arylamide functionalityXue Zhi Zhao, Kasthuraiah Maddali, Christophe Marchand, et al.
Viruses|January 25, 2025
Comparative Analyses of Antiviral Potencies of Second-Generation Integrase Strand Transfer Inhibitors (INSTIs) and the Developmental Compound 4d Against a Panel of Integrase Quadruple MutantsSteven J Smith, Xue Zhi Zhao, Stephen H Hughes, et al.
Pageof 17